期刊文献+

Properties and feasibility of using cancer stem cells in clinical cancer treatment 被引量:3

Properties and feasibility of using cancer stem cells in clinical cancer treatment
下载PDF
导出
摘要 Cancer treatment failure, drug resistance, or metastatic recurrence are thought to be caused mainly by the existence of a very small number of cancer stem cells(CSCs). The characteristics of this subgroup of cells include self-renewal, tumorigenesis, multiple differentiation and high invasiveness, metastasis, and drug resistance potential. Many studies have demonstrated that CSCs play important roles in tumor growth, spread and metastatic relapse after treatment, and are closely related to the prognosis of patients.From a therapeutic viewpoint, deep insights into the CSCs biology, development of specific therapeutic strategies for targeting CSCs, and characterization of their microenvironment could be an ideal way to combat cancer. Cancer treatment failure, drug resistance, or metastatic recurrence are thought to be caused mainly by the existence of a very small number of cancer stem cells(CSCs). The characteristics of this subgroup of cells include self-renewal, tumorigenesis, multiple differentiation and high invasiveness, metastasis, and drug resistance potential. Many studies have demonstrated that CSCs play important roles in tumor growth, spread and metastatic relapse after treatment, and are closely related to the prognosis of patients.From a therapeutic viewpoint, deep insights into the CSCs biology, development of specific therapeutic strategies for targeting CSCs, and characterization of their microenvironment could be an ideal way to combat cancer.
出处 《Cancer Biology & Medicine》 SCIE CAS CSCD 2016年第4期489-495,共7页 癌症生物学与医学(英文版)
基金 supported by the grants from the National Key Basic Research Program of China (Grant No. 2013CB910500) China National Key Projects for Infectious Disease (Grant No. 2012ZX10002-012) National Natural Science Foundation of China (Grant No. 81372647)
关键词 Cancer stem cells CANCERS treatment failure METASTASIS cancer therapy 肿瘤干细胞 肿瘤治疗 应用 临床 干细胞生物学 特异性治疗 癌症治疗 自我更新
  • 相关文献

参考文献1

二级参考文献39

  • 1Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999; 83:18-29. 被引量:1
  • 2Jin F, Xiang YB, Gao YT. Cancer survival in Shanghai, People's Republic of China. 1ARC Sci PubI 1998; 145:37-50. 被引量:1
  • 3Liang XH, Loncarevic IF, Tang ZY, Yu YQ, Zentgraf H, Schroder CH. Resection of hepatocellular carcinoma: oligocentric origin of recurrent and multinodular tumours. J GastroenterolHepatol 1991; 6:77-80. 被引量:1
  • 4Tsai TJ, Chau GY, Lui WY, et al. Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery 2000; 127:603-608. 被引量:1
  • 5Hoshida Y, Villanueva A, Kobayashi M, et al. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N EngI J Med 2008; 359:1995-2004. 被引量:1
  • 6Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002; 2:563-572. 被引量:1
  • 7Dalerba P, Cho RW, Clarke MF. Cancer stem cells: models and concepts. Annu Rev Med 2007; 58:267-284. 被引量:1
  • 8A1-Hajj M, Wicha MS, Benito-Hernandez A, Morrison S J, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100:3983-3988. 被引量:1
  • 9Hermann PC, Huber SL, Herder T, et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007; 1:313-323. 被引量:1
  • 10Sheridan C, Kishimoto H, Fuchs RK, et al. CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res 2006; 8:R59. 被引量:1

共引文献16

同被引文献7

引证文献3

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部